"Dr. Scott has been serving Inglewood, South Bay and surrounding communities for more than 40 years. His areas of focus include health maintenance, cardiopulmonary management, diabetes management, toxic exposure, and other internal medical conditions. Dr. Scott believes forming personal connections with patients is very important, and always ensures the time to answer patients questions, concerns, and provide guidance toward reaching their health goals. Patients appreciate his thorough communication, kindness, and ability to put them at ease during their office visits."

During the past decade, Chrishard Medical Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chrishard Medical Group" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "Meda Pharmaceuticals" with 1 trials sponsored, "Otsuka America Pharmaceutical" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chrishard Medical Group" #1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator and "Registrat-Mapi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chrishard Medical Group" are "Hypertension" (2 trials), "Chronic Disease" (1 trials), "Euvolemic Hyponatremia" (1 trials), "Hypervolemic Hyponatremia" (1 trials) and "Lower Back Pain" (1 trials). Many other conditions were trialed in "Chrishard Medical Group" in a lesser frequency.

Most popular intervention types in "Chrishard Medical Group" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Placebo" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Carisoprodol SR 500 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chrishard Medical Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Chrishard Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chrishard Medical Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chrishard Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".